Search research articles
Contact Us
Filters
Showing results (91-100 of 174) with videos related to
Page
of 18
Sort By:
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Clinical Biochemistry
|
September 25, 2016
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
Kazunori Murata, Samuel I McCash, Brittany Carroll, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One
|
November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
JAMA Network Open
|
March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
Angela K Green, Sara M Tabatabai, Xing Bai, et al.
Nature Medicine
|
January 23, 2023
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2024
Quality of Treatment Selection for Medicare Beneficiaries With Cancer
Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, et al.
Nature Medicine
|
March 18, 2023
Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 174) with videos related to
Sort By:
Page
of 18
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Clinical Biochemistry
|
September 25, 2016
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
Kazunori Murata, Samuel I McCash, Brittany Carroll, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One
|
November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
JAMA Network Open
|
March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
Angela K Green, Sara M Tabatabai, Xing Bai, et al.
Nature Medicine
|
January 23, 2023
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2024
Quality of Treatment Selection for Medicare Beneficiaries With Cancer
Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, et al.
Nature Medicine
|
March 18, 2023
Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Page
of 18